Lithium and Standard Therapy in Resistant Depression
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The principal clinical question is whether lithium is effective in reducing the risk of
suicidal behaviour in subjects with treatment-resistant depression and suicide risk.
Additionally aims of the study are: (a) to assess whether lithium is effective in improving
depressive symptomatology in subjects with treatment-resistant depression and suicide risk;
(b) to assess the tolerability profile of lithium.